ArticleScientific reports2025

BRD4 and MYB inhibition overcomes venetoclax resistance in EVI1-rearranged acute myeloid leukemia.

Weijia Zang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.